On the Platform, a growing number of evidence sources have some sort of variant information, however at this point, variant information is just an annotation. Having a variant entity would be highly advantageous as it would allow linking evidence from different sources. Also this would allow to share disease/target evidence (eg. from ClinVar) on the variant page on the Genetics Portal.
Related topics
Topic | Replies | Views | Activity | |
---|---|---|---|---|
What is the difference between the Open Targets Platform and the Open Targets Genetics Portal? | 0 | 415 | 16 June 2021 | |
OT Platform GWAS credible set issue | 2 | 20 | 21 April 2025 | |
Mismatched variant consequences between OT Genetics VEP data and the OT Platform evidence page? | 3 | 246 | 9 June 2022 | |
Are OpenTargets in collaboration with All of Us? | 2 | 109 | 26 February 2024 | |
25.03 Platform release now live! Open Targets Genetics data update | 2 | 97 | 28 March 2025 |